Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5025239> ?p ?o }
Showing triples 1 to 64 of
64
with 100 triples per page.
- Q5025239 subject Q7110135.
- Q5025239 subject Q8760145.
- Q5025239 subject Q8760194.
- Q5025239 abstract "Cambrex Corporation is a global, innovative life sciences company that provides products and services to accelerate the development and commercialization of small molecule active pharmaceutical ingredients (APIs). Cambrex has cGMP manufacturing facilities in the US (Charles City, IA), Europe (Karlskoga, Sweden, Milan, Italy and Hyderabad, India, and R&D centers in Tallinn, Estonia, Wiesbaden, Germany). The headquarters are located in East Rutherford, NJ.In 2007, Cambrex divested their biologics business to Lonza to focus on small molecule APIs.".
- Q5025239 foundingYear "1981".
- Q5025239 industry Q12140.
- Q5025239 keyPerson Q484876.
- Q5025239 keyPerson Q623268.
- Q5025239 keyPerson Q623279.
- Q5025239 location Q746830.
- Q5025239 numberOfEmployees "1000".
- Q5025239 revenue "3.742E8".
- Q5025239 type Q891723.
- Q5025239 wikiPageExternalLink www.cambrex.com.
- Q5025239 wikiPageExternalLink www.cambrex.com.
- Q5025239 wikiPageExternalLink Cambrex_Brochure1.pdf.
- Q5025239 wikiPageExternalLink Product_List.pdf.
- Q5025239 wikiPageExternalLink zenara.com.
- Q5025239 wikiPageWikiLink Q12140.
- Q5025239 wikiPageWikiLink Q1361.
- Q5025239 wikiPageWikiLink Q1721.
- Q5025239 wikiPageWikiLink Q1770.
- Q5025239 wikiPageWikiLink Q337492.
- Q5025239 wikiPageWikiLink Q484876.
- Q5025239 wikiPageWikiLink Q490.
- Q5025239 wikiPageWikiLink Q4917.
- Q5025239 wikiPageWikiLink Q537877.
- Q5025239 wikiPageWikiLink Q54732.
- Q5025239 wikiPageWikiLink Q623268.
- Q5025239 wikiPageWikiLink Q623279.
- Q5025239 wikiPageWikiLink Q674216.
- Q5025239 wikiPageWikiLink Q679692.
- Q5025239 wikiPageWikiLink Q7108.
- Q5025239 wikiPageWikiLink Q7110135.
- Q5025239 wikiPageWikiLink Q746830.
- Q5025239 wikiPageWikiLink Q8760145.
- Q5025239 wikiPageWikiLink Q8760194.
- Q5025239 wikiPageWikiLink Q891723.
- Q5025239 wikiPageWikiLink Q912807.
- Q5025239 foundation "New Jersey".
- Q5025239 homepage www.cambrex.com.
- Q5025239 industry Q12140.
- Q5025239 keyPeople "Aldo Magnini, Managing Director, Cambrex Profarmaco Milano".
- Q5025239 keyPeople "Gregory P. Sargen, CFO, Executive VP".
- Q5025239 keyPeople "Samantha M. Hanley, General Counsel and Corporate Secretary".
- Q5025239 keyPeople "Shawn P. Cavanagh, COO, Executive VP".
- Q5025239 keyPeople "Steven M. Klosk, CEO, President,".
- Q5025239 location Q746830.
- Q5025239 name "Cambrex Corporation".
- Q5025239 numEmployees "1000".
- Q5025239 revenue "$374.2 million USD".
- Q5025239 type Q891723.
- Q5025239 type Organization.
- Q5025239 type Agent.
- Q5025239 type Company.
- Q5025239 type Organisation.
- Q5025239 type Agent.
- Q5025239 type SocialPerson.
- Q5025239 type Thing.
- Q5025239 type Q43229.
- Q5025239 comment "Cambrex Corporation is a global, innovative life sciences company that provides products and services to accelerate the development and commercialization of small molecule active pharmaceutical ingredients (APIs). Cambrex has cGMP manufacturing facilities in the US (Charles City, IA), Europe (Karlskoga, Sweden, Milan, Italy and Hyderabad, India, and R&D centers in Tallinn, Estonia, Wiesbaden, Germany).".
- Q5025239 label "Cambrex Corporation".
- Q5025239 homepage www.cambrex.com.
- Q5025239 name "Cambrex Corporation".